MedTrace Logo

Transcranial Magnetic Stimulation (rTMS) Accelerates the Response to Escitalopram in Major Depression

NCT00149071 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2007-11-05

No results posted yet for this study

Summary

A doubleblind randomised trial with active versus sham rTMS in combination with escitalopram in patients with prior treatment resistant depression in an acute 12 weeks trial with subsequent 24 weeks study phase with active versus placebo citalopram

Conditions

Interventions

DEVICE

rTMS

15 treatments of rTMS active with a duration of 30 minutes each

DEVICE

TMS

Transcraniel Magnetic Stimulation active and sham

DEVICE

rTMS

active Transcranial Magnetic Stimulation

DEVICE

rTMS

daily for three weeks

Sponsors & Collaborators

  • Medicon Valley Academy

    collaborator UNKNOWN

  • Hillerod Hospital, Denmark

    lead OTHER

Principal Investigators

  • Line G Bretlau, MD · Psychiatric research Unit, Hilleroed Hospital, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2006-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149071 on ClinicalTrials.gov